BioXcel Therapeutics, Inc. Investing Cash Flow
BioXcel Therapeutics, Inc. (BTAI) reported Investing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-13
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $0.00.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $0.00.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2025 was $0.00.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $0.00.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$20.00K.
- BioXcel Therapeutics, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$139.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2026-08-13 | $0.00 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | $0.00 derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-15 | $0.00 derived: sum of 2 quarters · filed 2026-05-15 | $0.00 derived: sum of 3 quarters · filed 2026-05-15 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $0.00 derived: sum of 2 quarters · filed 2026-03-27 | $0.00 10-K · filed 2026-03-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-12 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $0.00 derived: sum of 2 quarters · filed 2025-03-28 | -$20.00K 10-K · filed 2025-03-28 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$20.00K 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | -$20.00K 10-Q · filed 2024-08-06 | |||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $0.00 derived: sum of 2 quarters · filed 2024-03-22 | -$19.00K derived: sum of 3 quarters · filed 2024-03-22 | -$139.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$19.00K derived: sum of 2 quarters · filed 2023-11-14 | -$139.00K 10-Q · filed 2023-11-14 | -$151.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$139.00K 10-Q · filed 2023-08-14 | -$151.00K derived: sum of 3 quarters · filed 2023-08-14 | -$168.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$120.00K 10-Q · filed 2023-05-09 | -$132.00K derived: sum of 2 quarters · filed 2023-05-09 | -$149.00K derived: sum of 3 quarters · filed 2023-05-09 | -$249.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$29.00K derived: sum of 2 quarters · filed 2023-03-16 | -$129.00K derived: sum of 3 quarters · filed 2023-03-16 | -$445.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$117.00K derived: sum of 2 quarters · filed 2022-11-14 | -$433.00K 10-Q · filed 2022-11-14 | -$703.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$416.00K 10-Q · filed 2022-08-11 | -$686.00K derived: sum of 3 quarters · filed 2022-08-11 | -$681.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$316.00K 10-Q · filed 2022-05-09 | -$586.00K derived: sum of 2 quarters · filed 2022-05-09 | -$581.00K derived: sum of 3 quarters · filed 2022-05-09 | -$616.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | -$270.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$265.00K derived: sum of 2 quarters · filed 2022-03-11 | -$300.00K derived: sum of 3 quarters · filed 2022-03-11 | -$316.00K 10-K · filed 2022-03-11 |
| 2020-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$30.00K derived: sum of 2 quarters · filed 2021-11-10 | -$46.00K 10-Q · filed 2021-11-10 | -$48.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | -$51.00K 10-Q · filed 2021-08-10 | -$53.00K derived: sum of 3 quarters · filed 2021-08-10 | -$96.00K derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | -$16.00K 10-Q · filed 2021-05-10 | -$18.00K derived: sum of 2 quarters · filed 2021-05-10 | -$61.00K derived: sum of 3 quarters · filed 2021-05-10 | -$286.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$45.00K derived: sum of 2 quarters · filed 2021-03-12 | -$270.00K derived: sum of 3 quarters · filed 2021-03-12 | -$870.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$43.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$268.00K derived: sum of 2 quarters · filed 2020-11-12 | -$868.00K 10-Q · filed 2020-11-12 | -$1.03M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$225.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$825.00K 10-Q · filed 2020-08-14 | -$983.00K derived: sum of 3 quarters · filed 2020-08-14 | -$1.04M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | -$600.00K 10-Q · filed 2020-05-12 | -$758.00K derived: sum of 2 quarters · filed 2020-05-12 | -$820.00K derived: sum of 3 quarters · filed 2020-05-12 | |
| 2018-12-31 | -$158.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$220.00K derived: sum of 2 quarters · filed 2020-03-09 | -$340.00K 10-K · filed 2020-03-09 | |
| 2018-09-30 | -$62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$182.00K 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | -$120.00K 10-Q · filed 2019-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |